Ahmedabad: Intas Pharmaceuticals Ltd has signed an exclusive license and supply agreement with Axantia Holding in the Middle East operating through its pharmaceutical subsidiaries; Pharma International Pharmaceutical & Chemical Manufacturing Co Ltd and Med City Pharmaceutical Industries for Ranibizumab (biosimilar of Lucentis).